Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Variant of a common protein plays a primary role in Type 2 diabetes and obesity

Scientists in France and the United States report that a variant of a common protein plays a primary role in Type 2 diabetes and obesity, key features of the "insulin resistance syndrome" that affects more than 50 million people in this country and a similar number in Europe.

19 Jul 2005

Diagnosing diabetes early saves lives

Australian Medical Association (AMA) President, Dr Mukesh Haikerwal, said today that while 520,000 Australians have been diagnosed with diabetes, there are probably as many again who remain undiagnosed, exposing them to serious complications caused by the disease, including kidney disease, heart attacks and eye problems.

19 Jul 2005

It's not the last word - for every new medical study there's bound to be another one later which contradicts it!

According to a review of 49 recent major medical studies, it has been discovered that nearly a third were later either totally contradicted or were found be much less effective than was originally thought.

19 Jul 2005

Scientists have identified a gene associated with both childhood and adult obesity

According to research published today in Nature Genetics, the team from Imperial College London, Hammersmith Hospital, London, and the CNRS Lille, France, have identified a gene (ENPP1), with strong links to childhood obesity in 3,147 in a sample of 4,886 French Caucasian individuals.

18 Jul 2005

Telephone helps reduce diabetes health disparities and improves health outcomes

In this high-tech world of electronic communications, the older, reliable form of communication via the telephone has proven effective in reaching out to older African-American women with diabetes.

18 Jul 2005

Cultural and language barriers may be hindering the treatment of South Asians with diabetes

South Asians are four times more likely than the rest of the UK population to have the condition. A follow up study has now begun into finding our how communication barriers could be overcome in medical consultation.

17 Jul 2005

New compound ruboxistaurin may decrease vision loss in diabete

A multicenter international study chaired by a Joslin Diabetes Center investigator and reported in the July issue of the American Diabetes Association's journal Diabetes brings hopeful news to the 18 million people in the United States -- and millions more worldwide -- with type 1 or type 2 diabetes.

15 Jul 2005

A new study shows that the number of Americans who had weight-loss surgery quadrupled between 1998 and 2002

A new study shows that the number of Americans who had weight-loss surgery quadrupled between 1998 and 2002.

13 Jul 2005

Giving oxygen may do more harm than good

Doctors and paramedics who give their patients oxygen - the most commonly administered "drug" in the world - may be doing more harm than good, a Queen's University researcher contends.

11 Jul 2005

New understanding of degeneration of brain cells in patients with Alzheimer's, Huntington's, and Parkinson's diseases

A ground-breaking new research approach to understanding the cellular processes of Alzheimer's and other degenerative diseases has revealed a promising pathway to the development of new types of drugs for these diseases.

11 Jul 2005

Low dose birth control pill raises heart attack risk, especially in some women

A new review suggests that low-dose birth control pills, which are generally considered to be safer than the pill of the past, still carries an increased risk for heart attack and stroke.

11 Jul 2005

Fat adults more likely to have increased insulin resistance, a risk marker for Type 2 diabetes

Adult lifestyle has more influence on your chances of developing diabetes than childhood experience, according to new research whose findings contradict previously-held beliefs.

6 Jul 2005

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Takeda Pharmaceuticals North America today announced that the company has submitted a New Drug Application (NDA) for a new oral medication that combines pioglitazone HCl and glimepiride, a sulfonylurea, to the United States Food and Drug Administration (FDA) for the treatment of type 2 diabetes.

30 Jun 2005

Major study says for diabetics with high blood pressure diuretics are the best option

A major new study has found that for people with type 2 diabetes and high blood pressure, cheaper diuretic medications may be the most cost-effective option in reducing hypertension.

29 Jun 2005

Saturated fats combined with genetic trait may make people more susceptible to type 2 diabetes

A University of Alberta team of researchers has discovered an additional 2 million Canadians who have a high fat diet or are overweight may be at increased risk for developing type 2 diabetes if they carry a particular type of common specific genetic trait known as a polymorphism.

29 Jun 2005

Europe tackles pre-diabetes

Diabetes is the fourth leading global cause of death and, with over 60 million people in Europe already estimated to have pre-diabetes, the situation is set to escalate at an alarming rate unless urgent action is taken.

29 Jun 2005

Exercise helps find genetic regions linked to prediabetes

People's bodies respond to exercise in different ways, and their genetic makeup is partly responsible.

28 Jun 2005

Parents whose children are born with a low birth weight run greater risk of dying of cardiovascular diseases

Even the fathers are at greater risk. These findings are published in a new report by Karolinska Institutet. The report shows that genetic factors affect both birth weight and the risk of cardiovascular diseases.

28 Jun 2005

Diuretics work better than newer and more costly medicines for diabetics with high blood pressure

Diuretics (water pills) work better than newer and more costly medicines in the treatment of high blood pressure and prevention of some forms of heart disease in people with type 2 diabetes, according to results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

28 Jun 2005

Metabasis and Merck collaborate to develop new treatment for diabetes, hyperlipidemia and obesity

Metabasis Therapeutics and Merck announced today that they have formed a collaboration to research, develop and commercialize novel small molecule therapeutics with potential to treat several diseases, including type II diabetes, hyperlipidemia and obesity, by activation of an enzyme in the liver called AMP-activated Protein Kinase (AMPK).

27 Jun 2005

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Variant of a common protein plays a primary role in Type 2 diabetes and obesity

Diagnosing diabetes early saves lives

It's not the last word - for every new medical study there's bound to be another one later which contradicts it!

Scientists have identified a gene associated with both childhood and adult obesity

Telephone helps reduce diabetes health disparities and improves health outcomes

Cultural and language barriers may be hindering the treatment of South Asians with diabetes

New compound ruboxistaurin may decrease vision loss in diabete

A new study shows that the number of Americans who had weight-loss surgery quadrupled between 1998 and 2002

Giving oxygen may do more harm than good

New understanding of degeneration of brain cells in patients with Alzheimer's, Huntington's, and Parkinson's diseases

Low dose birth control pill raises heart attack risk, especially in some women

Fat adults more likely to have increased insulin resistance, a risk marker for Type 2 diabetes

Takeda Pharmaceuticals submits NDA for a new oral diabetes medication

Major study says for diabetics with high blood pressure diuretics are the best option

Saturated fats combined with genetic trait may make people more susceptible to type 2 diabetes

Europe tackles pre-diabetes

Exercise helps find genetic regions linked to prediabetes

Parents whose children are born with a low birth weight run greater risk of dying of cardiovascular diseases

Diuretics work better than newer and more costly medicines for diabetics with high blood pressure

Metabasis and Merck collaborate to develop new treatment for diabetes, hyperlipidemia and obesity

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Newsletters you may be interested in